An immune suppressive tumor microenvironment in primary prostate cancer promotes tumor immune escape.

Autor: Anton, Angelyn¹ (AUTHOR), Hutchinson, Ryan¹ (AUTHOR), Hovens, Christopher M.^2,3 (AUTHOR), Christie, Michael² (AUTHOR), Ryan, Andrew⁴ (AUTHOR), Gibbs, Peter^1,5 (AUTHOR), Costello, Anthony^2,3,6 (AUTHOR), Peters, Justin^2,3,6 (AUTHOR), Neeson, Paul J.^7,8 (AUTHOR), Corcoran, Niall M.^2,3,5 (AUTHOR), Tran, Ben^1,7,9 (AUTHOR) ben.tran@petermac.org

Publikováno v: PLoS ONE. 11/27/2024, Vol. 19 Issue 11, p1-14. 14p.

Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface.

Autor: Gayen S; Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, 124, B. L. Saha Road, Tara Park, Behala, Kolkata, West Bengal, 700053, India., Mukherjee S; Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, 124, B. L. Saha Road, Tara Park, Behala, Kolkata, West Bengal, 700053, India., Dasgupta S; Department of Pharmaceutical Technology, Maulana Abul Kalam Azad University of Technology, Kolkata, West Bengal, 741249, India., Roy S; Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata-Group of Institutions, 124, B. L. Saha Road, Tara Park, Behala, Kolkata, West Bengal, 700053, India. souvikroy35@gmail.com.

Publikováno v: Apoptosis : an international journal on programmed cell death [Apoptosis] 2024 Dec; Vol. 29 (11-12), pp. 1879-1913. Date of Electronic Publication: 2024 Oct 01.

Prevalence and antibiotic susceptibility patterns of uropathogens in men with prostate cancer and benign prostate hyperplasia from Southwestern Nigeria.

Autor: Akinpelu, Sharon O.¹ (AUTHOR) sharon.akinpelupgs@stu.cu.edu.ng, Olasehinde, Grace I.¹ (AUTHOR), Ikuerowo, Stephen O.² (AUTHOR), Akinnola, Olayemi O.¹ (AUTHOR)

Publikováno v: BMC Microbiology. 9/21/2024, Vol. 24 Issue 1, p1-6. 6p.

Cytotoxic T-lymphocyte-associated 4 protein expression is associated with a high international prognostic score in advanced-stage classical Hodgkin lymphoma.

Autor: Pangaribuan, Flora Dameria¹ (AUTHOR), Ham, Maria Francisca^2,3 (AUTHOR), Mutmainnah, Mutiah⁴ (AUTHOR), Harahap, Agnes Stephanie^2,3 (AUTHOR) agnes.stephanie01@ui.ac.id

Publikováno v: BMC Research Notes. 7/8/2024, Vol. 17 Issue 1, p1-7. 7p.

Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab.

Autor: Topalian SL; Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Brahmer JR; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Gettinger SN; Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut., Smith DC; Department of Internal Medicine, University of Michigan, Ann Arbor., McDermott DF; Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts., Powderly JD; Carolina BioOncology Institute, Huntersville, North Carolina., Sosman JA; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; now with the Department of Medicine (Hematology and Oncology), Northwestern University Medical Center, Chicago, Illinois., Atkins MB; Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.; now with the Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia., Leming PD; The Christ Hospital Cancer Center, Cincinnati, Ohio., Spigel DR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee., Antonia SJ; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York., Wolchok JD; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York., Carvajal RD; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York.; now with the Department of Medicine, Columbia University Irving Medical Center, New York, New York., McHenry MB; Bristol-Myers Squibb, Princeton, New Jersey., Hosein F; Bristol-Myers Squibb, Princeton, New Jersey., Harbison CT; Bristol-Myers Squibb, Princeton, New Jersey., Grosso JF; Bristol-Myers Squibb, Princeton, New Jersey., Sznol M; Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut.

Publikováno v: JAMA oncology [JAMA Oncol] 2019 Oct 01; Vol. 5 (10), pp. 1411-1420.